Programmed death-1 (PD-1) is a type I transmembrane protein expressed on the surface of antigen-stimulated T cells on which it exerts an inhibitory effect when binding with its ligand programmed-death ligand 1 (PD-L1), which can be expressed by normal cells, immune cells and tumor cells [1]. The gene discussed is PDCD1; the disease is neoplasm.